NOVEL ALKALINE STABLE IMMUNOGLOBULIN-BINDING PROTEINS

European patent · EP3497117 · In force

Register entry

Publication number
EP3497117
Application number
EP17752349
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 7, 2017
Published
Jun 19, 2019
Granted
Jan 24, 2024
Protection ends at the latest
Aug 6, 2037
Next annual fee due
Aug 31, 2027
IPC classes
C07K 14/31 (2006.01)
C07K 1/22 (2006.01)
Priority
EP 16183710 11.08.2016
EP 16205707 21.12.2016
PCT application
PCT/EP2017/069976 07.08.2017
PCT publication
WO2018/029157 15.02.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Dec 4, 2024

    Change

    Published in Swissreg on 04.12.2024

  4. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  5. Jan 24, 2024

    Granted

    Published in Swissreg on 24.01.2024

Parties

Holder

NAVIGO PROTEINS GMBH

Navigo Proteins GmbH

Heinrich-Damerow-Strasse 1, 06120 Halle/Saale, DE

Inventor

KNICK, Paul

06120 Halle/Saale, DE

FIEDLER, Erik

06120 Halle/Saale, DE

HAUPTS, Ulrich

06120 Halle/Saale, DE

MEYSING, Maren

06120 Halle/Saale, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.